These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1901688)

  • 1. Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.
    Brooks DA; McCourt PA; Gibson GJ; Ashton LJ; Shutter M; Hopwood JJ
    Am J Hum Genet; 1991 Apr; 48(4):710-9. PubMed ID: 1901688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoquantification of the low abundance lysosomal enzyme N-acetylgalactosamine 4-sulphatase.
    Brooks DA; McCourt PA; Gibson GJ; Hopwood JJ
    J Inherit Metab Dis; 1990; 13(1):108-20. PubMed ID: 2109145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.
    Litjens T; Brooks DA; Peters C; Gibson GJ; Hopwood JJ
    Am J Hum Genet; 1996 Jun; 58(6):1127-34. PubMed ID: 8651289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.
    Bradford TM; Litjens T; Parkinson EJ; Hopwood JJ; Brooks DA
    Biochemistry; 2002 Apr; 41(15):4962-71. PubMed ID: 11939792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.
    Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ
    Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.
    Vine DT; McGovern MM; Schuchman EH; Haskins ME; Desnick RJ
    J Clin Invest; 1982 Feb; 69(2):294-302. PubMed ID: 6799547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild feline mucopolysaccharidosis type VI. Identification of an N-acetylgalactosamine-4-sulfatase mutation causing instability and increased specific activity.
    Yogalingam G; Hopwood JJ; Crawley A; Anson DS
    J Biol Chem; 1998 May; 273(22):13421-9. PubMed ID: 9593674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype.
    Tønnesen T; Gregersen HN; Güttler F
    J Med Genet; 1991 Jul; 28(7):499-501. PubMed ID: 1832719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase.
    Anson DS; Taylor JA; Bielicki J; Harper GS; Peters C; Gibson GJ; Hopwood JJ
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):789-94. PubMed ID: 1320379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.
    Turner CT; Hopwood JJ; Bond CS; Brooks DA
    Mol Genet Metab; 1999 Jul; 67(3):194-205. PubMed ID: 10381327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of N-acetylgalactosamine-4-sulphatase induces a multiple sulphatase deficiency in mucopolysaccharidosis-type-VI fibroblasts.
    Anson DS; Muller V; Bielicki J; Harper GS; Hopwood JJ
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):657-62. PubMed ID: 8379921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.
    Fillat C; Simonaro CM; Yeyati PL; Abkowitz JL; Haskins ME; Schuchman EH
    J Clin Invest; 1996 Jul; 98(2):497-502. PubMed ID: 8755662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical characterization of feline and human N-acetylgalactosamine 4-sulfatase.
    Brooks DA; Gibson GJ; Hopwood JJ
    Biochem Med Metab Biol; 1994 Oct; 53(1):58-66. PubMed ID: 7857682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts.
    Taylor JA; Gibson GJ; Brooks DA; Hopwood JJ
    Biochem J; 1990 Jun; 268(2):379-86. PubMed ID: 2114091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
    Perkins KJ; Muller V; Weber B; Hopwood JJ
    Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
    Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
    J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer.
    Peters C; Rommerskirch W; Modaressi S; von Figura K
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):499-504. PubMed ID: 1904721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of arylsulfatase B activity and diagnosis of Maroteaux-Lamy syndrome.
    Hwu WL; Wang TR
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1991; 32(5):280-5. PubMed ID: 1776456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype.
    Litjens T; Morris CP; Robertson EF; Peters C; von Figura K; Hopwood JJ
    Hum Mutat; 1992; 1(5):397-402. PubMed ID: 1301949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity.
    Hopwood JJ; Elliott H; Muller VJ; Saccone GT
    Biochem J; 1986 Mar; 234(3):507-14. PubMed ID: 3087346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.